Microparticles as Biomarkers of Blood Coagulation in Cancer
نویسندگان
چکیده
منابع مشابه
Microparticles as Biomarkers of Blood Coagulation in Cancer
Cancer is associated with hypercoagulopathy and increased risk of thrombosis. This negatively influences patient morbidity and mortality. Cancer is also frequently complicated by the development of venous thromboembolism (VTE). Tumor-derived tissue factor (TF)-bearing microparticles (MPs) are associated with VTE events in malignancy. MPs are small membrane vesicles released from many different ...
متن کاملMicroparticles as Potential Biomarkers of Cardiovascular Disease
Primary prevention of cardiovascular disease is a choice of great relevance because of its impact on health. Some biomarkers, such as microparticles derived from different cell populations, have been considered useful in the assessment of cardiovascular disease. Microparticles are released by the membrane structures of different cell types upon activation or apoptosis, and are present in the pl...
متن کاملMicroparticles and a P-Selectin-Mediated Pathway of Blood Coagulation
Alessandro Celia,c, Roberto Lorenzetb, Barbara C. Furiec and Bruce Furiec,∗ Laboratorio di Biologia Cellulare Respiratoria, Dipartimento Cardiotoracico dell’Universit à di Pisa, Pisa, Italy Antonio Taticchi Unit for Atherosclerosis and Thrombosis, Istituto Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy Center for Hemostasis and Thrombosis Research, Beth I...
متن کاملMicroRNAs as biomarkers associated with bladder cancer
Bladder cancer is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs are emerging as diagnostic biomarkers for bladder cancer. Specific miRNA profiles have been identified for several samples from patients with bladder cancer. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles...
متن کاملPlatelet-derived microparticles and coagulation activation in breast cancer patients.
In the mid 1800s Trousseau observed cancer-associated thrombosis, of which the underlying pathogenesis still remains unknown. We performed a prospective study on platelet-derived microparticles (PMP) and their procoagulant potential in breast cancer patients. Fifty-eight breast cancer patients and 13 women with benign breast tumors were included in the study. Microparticles (MP) were examined b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomarkers in Cancer
سال: 2015
ISSN: 1179-299X,1179-299X
DOI: 10.4137/bic.s30347